Deconjugation of bile acids by human intestinal bacteria implanted in germ-free rats

Lipids ◽  
1987 ◽  
Vol 22 (9) ◽  
pp. 669-671 ◽  
Author(s):  
Toshiyuki Chikai ◽  
Hiroyuki Nakao ◽  
Kiyohisa Uchida
2012 ◽  
Vol 109 (8) ◽  
pp. 1433-1441 ◽  
Author(s):  
Laura Hanske ◽  
Wolfram Engst ◽  
Gunnar Loh ◽  
Silke Sczesny ◽  
Michael Blaut ◽  
...  

Cyanidin 3-glucoside (C3G) is one of the major dietary anthocyanins implicated in the prevention of chronic diseases. To evaluate the impact of human intestinal bacteria on the fate of C3G in the host, we studied the metabolism of C3G in human microbiota-associated (HMA) rats in comparison with germ-free (GF) rats. Urine and faeces of the rats were analysed for C3G and its metabolites within 48 h after the application of 92 μmol C3G/kg body weight. In addition, we tested the microbial C3G conversion in vitro by incubating C3G with human faecal slurries and selected human gut bacteria. The HMA rats excreted with faeces a three times higher percentage of unconjugated C3G products and a two times higher percentage of conjugated C3G products than the GF rats. These differences were mainly due to the increased excretion of 3,4-dihydroxybenzoic acid, 2,4,6-trihydroxybenzaldehyde and 2,4,6-trihydroxybenzoic acid. Only the urine of HMA rats contained peonidin and 3-hydroxycinnamic acid and the percentage of conjugated C3G products in the urine was decreased compared with the GF rats. Overall, the presence of intestinal microbiota resulted in a 3·7 % recovery of the C3G dose in HMA rats compared with 1·7 % in GF rats. Human intestinal bacteria rapidly degraded C3G in vitro. Most of the C3G products were also found in the absence of bacteria, but at considerably lower levels. The higher concentrations of phenolic acids observed in the presence of intestinal bacteria may contribute to the proposed beneficial health effects of C3G.


1976 ◽  
Vol 11 (3) ◽  
pp. 167-174 ◽  
Author(s):  
Kunihiko Shindo ◽  
Kokichi Fukushima

Lipids ◽  
2000 ◽  
Vol 35 (6) ◽  
pp. 639-644 ◽  
Author(s):  
Seiko Narushima ◽  
Kikuji Iton ◽  
Kazuo Kuruma ◽  
Kiyohisa Uchida

Antibiotics ◽  
2021 ◽  
Vol 10 (2) ◽  
pp. 180
Author(s):  
Kouki Shimizu ◽  
Issei Seiki ◽  
Yoshiyuki Goto ◽  
Takeshi Murata

The intestinal pH can greatly influence the stability and absorption of oral drugs. Therefore, knowledge of intestinal pH is necessary to understand the conditions for drug delivery. This has previously been measured in humans and rats. However, information on intestinal pH in mice is insufficient despite these animals being used often in preclinical testing. In this study, 72 female ICR mice housed in SPF (specific pathogen-free) conditions were separated into nine groups to determine the intestinal pH under conditions that might cause pH fluctuations, including high-protein diet, ageing, proton pump inhibitor (PPI) treatment, several antibiotic treatment regimens and germ-free mice. pH was measured in samples collected from the ileum, cecum and colon, and compared to control animals. An electrode, 3 mm in diameter, enabled accurate pH measurements with a small amount of gastrointestinal content. Consequently, the pH values in the cecum and colon were increased by high-protein diet, and the pH in the ileum was decreased by PPI. Drastic alkalization was induced by antibiotics, especially in the cecum and colon. The alkalized pH values in germ-free mice suggested that the reduction in the intestinal bacteria caused by antibiotics led to alkalization. Alkalization of the intestinal pH caused by antibiotic treatment was verified in mice. We need further investigations in clinical settings to check whether the same phenomena occur in patients.


Gut ◽  
1968 ◽  
Vol 9 (1) ◽  
pp. 22-27 ◽  
Author(s):  
M J Hill ◽  
B S Drasar

Sign in / Sign up

Export Citation Format

Share Document